Reduce Bolus Injection of Bivalirudin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.

Also called NCT03588611

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 204 participants (enrolled count) (from the registry)
Sponsor
Han Yaling, MD (from the registry)
Registry
  • NCT NCT03588611
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03588611. Randomized; double masking; primary purpose treatment. Start 2019-10-01 (actual); primary completion 2021-06-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reduce Bolus Injection of Bivalirudin
Condition
Acute Coronary Syndrome
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Bivalirudin
Lead sponsor
Han Yaling, MD (class: other)

Record details

Record id
cardio:ct-nct03588611
Content hash
4ee65303389274dacb16b8fa20e6459d0567288f5347f29bda492e08ee05bf77